Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Giantin mediates Golgi localization of Gal3-O-sulfotransferases and affects salivary mucin sulfation in patients with Sjögren's disease.
Nuñez M, Carvajal P, Aguilera S, Barrera MJ, Matus S, Couto A, Landoni M, Boncompain G, González S, Molina C, Pino K, Indo S, Figueroa L, González MJ, Castro I. Nuñez M, et al. Among authors: indo s. JCI Insight. 2024 Nov 22;9(22):e171585. doi: 10.1172/jci.insight.171585. JCI Insight. 2024. PMID: 39388276 Free PMC article.
Epidemiological and clinical description of patients with oropharyngeal cancer treated in a public oncology referral hospital in Chile.
Felipe Carvajal V, Felipe Cardemil M, Vásquez BP, Oliva CE, Barría TA, Bruna MA, Moyano LA, Bustos FA, Muñoz PA, Araya CF, Oyarzún JE, Villa EA, Floriano FA, Del Rio AJ, Indo SR, Castellón EA, Contreras HR. Felipe Carvajal V, et al. Among authors: indo sr. Ecancermedicalscience. 2024 Mar 26;18:1685. doi: 10.3332/ecancer.2024.1685. eCollection 2024. Ecancermedicalscience. 2024. PMID: 38566759 Free PMC article.
New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.
Castillo AF, Orlando UD, Maloberti PM, Prada JG, Dattilo MA, Solano AR, Bigi MM, Ríos Medrano MA, Torres MT, Indo S, Caroca G, Contreras HR, Marelli BE, Salinas FJ, Salvetti NR, Ortega HH, Lorenzano Menna P, Szajnman S, Gomez DE, Rodríguez JB, Podesta EJ. Castillo AF, et al. Among authors: indo s. Cell Mol Life Sci. 2021 Mar;78(6):2893-2910. doi: 10.1007/s00018-020-03679-5. Epub 2020 Oct 17. Cell Mol Life Sci. 2021. PMID: 33068124 Free PMC article.
Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).
Nishina T, Moriwaki T, Shimada M, Higashijima J, Sakai Y, Masuishi T, Ozeki M, Amagai K, Negoro Y, Indo S, Denda T, Sato M, Yamamoto Y, Nakajima G, Mizuta M, Takahashi I, Hiroshima Y, Ishida H, Maeba T, Hyodo I. Nishina T, et al. Among authors: indo s. Clin Colorectal Cancer. 2016 Sep;15(3):236-42. doi: 10.1016/j.clcc.2015.12.001. Epub 2015 Dec 17. Clin Colorectal Cancer. 2016. PMID: 26778644 Clinical Trial.
18 results